Table of contents
Volume 89, Issue 2
Published online 15 July 2003 (223-423)
Commentary |
Minireview |
Tutorial Paper |
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letter to the Editor |
Book Review |
Erratum |
Corrigendum
Editorial
The oncologists' and radiologists' PET FREE
Robin A Weiss
Br J Cancer 89: 223; doi:10.1038/sj.bjc.6601190
Commentary
Investing in new technology: the PET experience FREE
I Bradbury, K Facey, G Laking and P Sharp
Br J Cancer 89: 224-227; doi:10.1038/sj.bjc.6601109
Minireview
New molecular pathways in angiogenesis FREE
D C Sullivan and R Bicknell
Br J Cancer 89: 228-231; doi:10.1038/sj.bjc.6601107
Tutorial Paper
Survival Analysis Part I: Basic concepts and first analyses FREE
T G Clark, M J Bradburn, S B Love and D G Altman
Br J Cancer 89: 232-238; doi:10.1038/sj.bjc.6601118
Clinical
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid FREE
P Correale, S Messinese, S Marsili, F Ceciarini, D Pozzessere, R Petrioli, M Sabatino, D Cerretani, M Pellegrini, T Di Palma, A Neri, A Calvanese, E Pinto, G Giorgi and G Francini
Br J Cancer 89: 239-242; doi:10.1038/sj.bjc.6601045
Alveolar soft-part sarcoma responding to interferon alpha-2b FREE
K J Roozendaal, B de Valk, J J A ten Velden, H J van der Woude and B B R Kroon
Br J Cancer 89: 243-245; doi:10.1038/sj.bjc.6601074
ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases FREE
F Cappuzzo, C Calandri, S Bartolini and L Crinò
Br J Cancer 89: 246-247; doi:10.1038/sj.bjc.6601116
Phase 1 study of temozolamide (TMZ) combined with procarbazine (PCB) in patients with gliomas FREE
E S Newlands, T Foster and S Zaknoen
Br J Cancer 89: 248-251; doi:10.1038/sj.bjc.6601043
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma FREE
K Dalhoff, J Dancey, L Astrup, T Skovsgaard, K J Hamberg, F J Lofts, O Rosmorduc, S Erlinger, J Bach Hansen, W P Steward, T Skov, F Burcharth and T R J Evans
Br J Cancer 89: 252-257; doi:10.1038/sj.bjc.6601104
Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid FREE
J A Christian, G J R Cook and C Harmer
Br J Cancer 89: 258-261; doi:10.1038/sj.bjc.6601072
Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane FREE
H Anderson, J T Yap, P Wells, M P Miller, D Propper, P Price and A L Harris
Br J Cancer 89: 262-267; doi:10.1038/sj.bjc.6601105
Molecular and Cellular Pathology
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen FREE
D Coradini, E Biganzoli, C Pellizzaro, S Veneroni, S Oriana, F Ambrogi, R Erdas, P Boracchi, M G Daidone and E Marubini
Br J Cancer 89: 268-270; doi:10.1038/sj.bjc.6601060
Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome FREE
P N Span, J Bussink, P Manders, L V A M Beex and C G J Sweep
Br J Cancer 89: 271-276; doi:10.1038/sj.bjc.6601122
Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast FREE
G P Boland, A Mckeown, K C Chan, R Prasad, W F Knox and N J Bundred
Br J Cancer 89: 277-283; doi:10.1038/sj.bjc.6601013
Prognostic factors for patients with hepatic metastases from breast cancer FREE
L Wyld, E Gutteridge, S E Pinder, J J James, S Y Chan, K L Cheung, J F R Robertson and A J Evans
Br J Cancer 89: 284-290; doi:10.1038/sj.bjc.6601038
Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patients FREE
X-Y Dong, Y-R Su, X-P Qian, X-A Yang, X-W Pang, H-Y Wu and W-F Chen
Br J Cancer 89: 291-297; doi:10.1038/sj.bjc.6601062
Retinoblastoma protein expression is an independent predictor of both radiation response and survival in muscle-invasive bladder cancer FREE
M Agerbaek, J Alsner, N Marcussen, F Lundbeck and H von der Maase
Br J Cancer 89: 298-304; doi:10.1038/sj.bjc.6601063
Genetics and Genomics
Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues FREE
M V Dwek and A A Alaiya
Br J Cancer 89: 305-307; doi:10.1038/sj.bjc.6601008
Further observations on LKB1/STK11 status and cancer risk in Peutz–Jeghers syndrome FREE
W Lim, N Hearle, B Shah, V Murday, S V Hodgson, A Lucassen, D Eccles, I Talbot, K Neale, A G Lim, J O'Donohue, A Donaldson, R C Macdonald, I D Young, M H Robinson, P W R Lee, B J Stoodley, I Tomlinson, D Alderson, A G Holbrook, S Vyas, E T Swarbrick, A A M Lewis, R K S Phillips and R S Houlston
Br J Cancer 89: 308-313; doi:10.1038/sj.bjc.6601030
Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines FREE
O Margalit, L Eisenbach, N Amariglio, N Kaminski, A Harmelin, R Pfeffer, M Shohat, G Rechavi and R Berger
Br J Cancer 89: 314-319; doi:10.1038/sj.bjc.6600977
Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers FREE
Y-L Chang, C-T Wu, J-Y Shih and Y-C Lee
Br J Cancer 89: 320-326; doi:10.1038/sj.bjc.6601041
PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells FREE
N Tiffin, R D Williams, J Shipley and K Pritchard-Jones
Br J Cancer 89: 327-332; doi:10.1038/sj.bjc.6601040
Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer FREE
R Mort, L Mo, C McEwan and D W Melton
Br J Cancer 89: 333-337; doi:10.1038/sj.bjc.6601061
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms FREE
N Fukushima, N Sato, F Sahin, G H Su, R H Hruban and M Goggins
Br J Cancer 89: 338-343; doi:10.1038/sj.bjc.6601039
Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis FREE
J-R Hsiao, Y-T Jin, S-T Tsai, A-L Shiau, C-L Wu and W-C Su
Br J Cancer 89: 344-349; doi:10.1038/sj.bjc.6601003
Experimental Therapeutics
Temporal heterogeneity in oxygen tension in human melanoma xenografts FREE
K G Brurberg, B A Graff and E K Rofstad
Br J Cancer 89: 350-356; doi:10.1038/sj.bjc.6601047
The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro FREE
M A I Abou El Hassan, H M W Verheul, A S Jorna, C Schalkwijk, J van Bezu, W J F van der Vijgh and A Bast
Br J Cancer 89: 357-362; doi:10.1038/sj.bjc.6601022
Differential modulation of the TRAIL receptors and the CD95 receptor in colon carcinoma cell lines FREE
C M M van Geelen, E G E de Vries, T K P Le, R P van Weeghel and S de Jong
Br J Cancer 89: 363-373; doi:10.1038/sj.bjc.6601065
Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–
1 integrin complex in colon cancer cells FREE
N Ahmed, K Oliva, Y Wang, M Quinn and G Rice
Br J Cancer 89: 374-384; doi:10.1038/sj.bjc.6601098
Oestradiol enhances tumour regression induced by B7-1/IL-2 adenoviral gene transfer in a murine model of breast cancer FREE
C Dabrosin, K Palmer and J Gauldie
Br J Cancer 89: 385-390; doi:10.1038/sj.bjc.6601099
AKT inhibition is associated with chemosensitisation in the pancreatic cancer cell line MIA-PaCa-2 FREE
B N Fahy, M Schlieman, S Virudachalam and R J Bold
Br J Cancer 89: 391-397; doi:10.1038/sj.bjc.6601037
Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics FREE
H J Jones, D I Vernon and S B Brown
Br J Cancer 89: 398-404; doi:10.1038/sj.bjc.6601101
Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours FREE
D K Kelleher, J Bastian, O Thews and P Vaupel
Br J Cancer 89: 405-411; doi:10.1038/sj.bjc.6601036
In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cells FREE
N Sidell, M Pasquali, S Malkapuram, A B Barua, T Wanichkul and R K Wada
Br J Cancer 89: 412-419; doi:10.1038/sj.bjc.6601108
Letter to the Editor
A consistent shift in VEGF determinations between two different ELISA batch numbers FREE
K Werther, I J Christensen and H J Nielsen the Danish RANX05 Corolectal Cancer Study Group
Br J Cancer 89: 420; doi:10.1038/sj.bjc.6601123
Book Review
The Macrophage (2nd Edn) FREE
M J Embleton
Br J Cancer 89: 421; doi:10.1038/sj.bjc.6601103
Erratum
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer FREE
J-L Boulay, G Mild, A Lowy, J Reuter, M Lagrange, L Terracciano, U Laffer, R Herrmann and C Rochlitz
Br J Cancer 89: 422; doi:10.1038/sj.bjc.6601020
Corrigendum
The epidemiology of conjunctival squamous cell carcinoma in Uganda FREE
R Newton, J Ziegler, C Ateenyi-Agaba, L Bousarghin, D Casabonne, V Beral, E Mbidde, L Carpenter, G Reeves, D M Parkin, H Wabinga, S Mbulaiteye, H Jaffe, D Bourboulia, C Boshoff, A Touzé and P Coursaget the Uganda Kaposi's Sarcoma Study Group
Br J Cancer 89: 423; doi:10.1038/sj.bjc.6601128
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
